Speaking of Jung: Interviews with Jungian Analysts cover image

Speaking of Jung: Interviews with Jungian Analysts

Episode 128: Linda Carter

Nov 8, 2023
Jungian analyst Linda Carter discusses her upcoming paper on using ketamine in analytic treatment and the intersection between nursing and analytical psychology. They explore the effectiveness of ketamine in treating trauma and depression, the challenges of working with traumatized individuals, and the decline of free play in today's society. They also delve into the impact of ketamine on the brain's default mode network and emphasize the importance of community support for mental health.
01:19:53

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • Ketamine is being explored as a therapeutic tool in Jungian analysis, showing effectiveness in treating patients who have not responded to other medications or therapies.
  • Psychopharmacology, when used in conjunction with psychotherapy, can be more effective than either treatment alone, especially for individuals experiencing profound depression or other psychiatric illnesses.

Deep dives

The use of ketamine in Jungian analysis

Ketamine is being explored as a therapeutic tool in Jungian analysis. It has shown effectiveness in treating patients who have not responded to other medications or therapies. Ketamine has psychedelic effects, which can help anesthetize trauma complexes and allow other internal figures to come forward. The use of ketamine in analysis aims to calm the default mode network in the brain, allowing for creative thinking, mind wandering, and a sense of connectedness. However, it is important to note that the use of ketamine should not be seen as a quick fix, and the long-term effects and cost of treatment are among the considerations to take into account.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner